Panel Discussion: What Should Be the Optimal Design for Percutaneous Aortic Valve Therapy? Raoul Bonan, MD Institut de Cardiologie de Montreal.

Slides:



Advertisements
Similar presentations
” سبحانك لا علم لنا إلا ما علمتنا إنك أنت العليم الحكيم “
Advertisements

Room Setup, Access, and Closure August 2013 Innovating for life. UC a EE.
Trileaflet Aortic Valve. Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed.
Starting an Extraction Program Getting your ducks in a row… Samir Saba, MD, FHRS Director, Cardiac Electrophysiology University of Pittsburgh Medical Center.
ACC 2015 Michael J Reardon, MD, FACC On Behalf of the CoreValve US Investigators A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic.
Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From.
The Structural Heart Disease Program your partners for advanced interventional cardiology Structural Heart Disease is a new branch of cardiology involving.
Biondi-Zoccai: Peripheral interventions – metcardio.org Basic principles of peripheral interventions Giuseppe Biondi Zoccai University.
PROF. DR. ALPAY ÇELIKER. Complication is destiny of the every pediatric cardiologist who is working at interventional area.
Dr R H Stables Cardiothoracic Centre Liverpool, UK Thoracic Aortic Stent Grafting.
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
Pediatric Interventions Cardiac Catheterization and Valvuloplasty.
Chapter 16 Assessment of Hemodynamic Pressures
Axel Linke University of Leipzig Heart Center, Leipzig, Germany Sabine Bleiziffer German Heart Center, Munich, Germany Johan Bosmans University Hospital.
Trancatheter Aortic Valve Implantation (TAVI)
AORTIC ANEURYSM Prepared by: Dr. Hanan Said Ali. Objectives Define aortic aneurysm. Enumerate causes. Classify aortic aneurysm. Enumerate clinical manifestation.
Secondary Intervention in Unfavorable AAA Neck Anatomy Congress Symposium 2007 John T. Collins, MD Borgess Medical Center Kalamazoo, MI.
Cardiac Cath and Angiocardiography SPRING Catherization Studies and Procedures Adults Children.
How do you manage this patient?. Diagnostic An adequate diagnostic workup: Documents the presence and type of ASD(s) Determines the size (diameter) of.
VIRTUAL SIMULATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION Jenna Smetana and Jessica Sider, Swanson School of Engineering THE TAVI PROCEDURE IS FEASIBLE.
Transcatheter Cardiovascular Therapeutics 2008 (October 12-17, 2008 · Washington, DC) First-in-Human Report: Initial Experience with a Stentless and Retrievable.
EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.
1 Jeffrey J. Popma, MD Professor of Medicine Harvard Medical School Director, Interventional Cardiology Beth Israel Deaconess Medical Center Boston, MA.
VSD post TAVR: Mechanisms, Presentation and Management
Nelson Lim Bernardo, MD Washington Hospital Center
Issues and Current Situations in the Development of Endovascular Treatment Devices for Pediatric Cardiology in the US – US Industry Dan Gutfinger, MD,
Valvuloplasty Scoring Balloon for the Treatment of Critical Aortic Valve Stenosis - Design of a FIM Study - Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC.
Extending the Boundaries of TAVR: Future Directions
Conditions & Treatments Conditions Treatments Our experts cardiologist diagnose and treat patients with coronary artery disease, heart failure, valve.
TAVR Medtronic CoreValve® Subclavian Approach Clinical Data
Is Transoesophageal Echocardiography during TAVR Essential?
Design & Product Development Larry L Wood
The Role of the Heart Team in the Cath Lab in 2017
Direct Flow Medical Experience with a Conformable, Repositionable, Retrievable, Percutaneous Aortic Valve Reginald Low MD University of California,Davis.
Optimizing Valve Sizing: Role of CT vs. Echo
Patient Selection for TAVI:
Direct Carotid Access for Acute Stroke Intervention
Valve Durability Considerations: Fluid Dynamic Principles, Assessment Techniques, Predictors, and Minimum Standards Jorge H. Jimenez, Ph.D. Georgia Institute.
EVOLUT R, Next Generation, and Future
Special Hospital for surgical diseases “Filip Vtori”, Skopje
Institut de Cardiologie de Montreal
Percutaneous Heart Valves: Standards and Modeling Timothy Kelley, MS
Transfemoral Access Devices & Tips for Closures Devices
Alec Vahanian, FESC, FRCP Bichat Hospital, Paris
Carotid Artery Stenting Predictors of procedural and clinical success
Early Outcomes with the Evolut R Repositionable Self-Expanding Transcatheter Aortic Valve in the United States Mathew Williams, MD, For the Evolut R US.
Pediatric cardiac catheterization Part 1 - balloon procedures David Shim, MD The Heart Center Children’s Hospital Medical Center Cincinnati, Ohio.
Optimizing Valve Sizing: Role of CT vs. Echo
5th Meeting on Acute Cardiac Care and Emergency Medicine, 2016 Vilnius
Direct Flow Medical Experience with a Conformable, Repositionable Retrievable Percutaneous Aortic Valve Reginald Low MD University of California, Davis.
TAVI „Catch me if you can!“
Keith Dawkins MD FRCP FACC FSCAI Global Chief Medical Officer
The Hybrid OR for Valve Therapy
Opportunities to Study Valve Iterations and Modifications in the US
A Step-by-Step Approach Using the Edwards SapienTransfemoral TAVI System E Murat Tuzcu Cleveland Clinic Disclosure: None.
Rush University Medical Center, Chicago, IL
Progress with the Sadra Medical Lotus™ Valve System
Axel Linke University of Leipzig Heart Center, Leipzig, Germany
Larry L. Wood Corporate Vice President Edwards Lifesciences
One-stop Hybrid Cardiac Surgery
CRT 2010 Washington DC, January 21, 2010
One Year Outcomes in Real World Patients Treated with Transcatheter Aortic Valve Implantation The ADVANCE Study Axel Linke University of Leipzig Heart.
Dynamic Mitral Valve Ring Annuloplasty: Micardia Concept
TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES David WM Muller, MBBS,
Cardiac Cath NUR 422.
Transcatheter Aortic Valve Replacement
Objectives of patients flow map
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections
Technique of interventional repair in adult aortic coarctation
From Theory to Practice: Creating a limb Preservation Center
Presentation transcript:

Panel Discussion: What Should Be the Optimal Design for Percutaneous Aortic Valve Therapy? Raoul Bonan, MD Institut de Cardiologie de Montreal

Presenter Disclosure Information Raoul Bonan, MD Scientific Advisory Board and/or Consultant Medtronic Vascular Clinical Research Agreements Multiple Medical Device Clinical Investigations Including CoreValve

TAVI wish list Ease of use Minimally invasive Accurate deployment without support Repositionable and retrievable No para-valvular leak No stroke No or minimal conduction system disturbance Multi sizes from 16 to 31 mm Durability comparable to surgical valve

Ease of Use Low profile catheter system Flexible Easily identify by X Rays and Echo Achieving large AVA > 1.5 cm2

Minimally invasive Low profile catheter system Versatility: Trans-Femoral, Axillary, Apical

Accurate deployment without support Different part of the device easily identify No or minimal aortic flow interruption No need any support and pacing

Repositionable and Retrievable During deployment Axis Para-valvular leak Retrievable: Size consideration Specific anatomy

No para-valvular leak Potential expansion to younger and healthier patients Conformability to the annulus

No stroke Embolic protection device

No or minimal conduction system disturbance Balloon dilatation Device: Length Stiffness Level of implantation

Multi sizes from 16 to 31 mm To accommodate from aortic valve stenosis to aortic valve regurgitation

Durability comparable to surgical valve Actual bench data are equivalent Expected equivalent long term quality

Material Selection Thickness Tensile Strength Pliability Valve Design Leaflet Geometry Supra-annular Valve Performance Clinical Data Bench Testing In summary, CoreValve’s durability is the product of the proper material selection matched with the right bioprosthetic valve design: Porcine pericardium’s thin profile is well suited for transcatheter valve design and its strength far exceeds peak physiological pressures; it also is a pliable material that reduces stress by preventing the buckling and deforming seen in thicker tissue valves. Additionally, CoreValve is designed to reduce stresses on valve leaflets through employing a high commissure and supra-annular valve location. Since high leaflet stress contributes to valve tearing, delamination, and eventual failure, CoreValve is uniquely designed and built for performance and durability.

Why a Team? Simple solution to a complex problem or Complex solution to simple problem? Multidisciplinary inputs, knowledge, competence and skills Abolish “Turf” battle Prepare the future

The TEAM “functional” multidisciplinary team . - ≥ 2 interventional cardiologists. - ≥ 2 cardiac surgeons. - a dedicated cath-lab team - a dedicated clinic with a nurse specialist - dedicated imaging specialists. - dedicated cardiac anesthetists. - a (“elderly”) medicine specialist.

Knowledge /Competence The TEAM Before During After Diagnostic Skills Immediate Decision Knowledge /Competence Plan Follow up Backup plan Closure / vascular Communication

Information to patient, Family Inform consent Follow up The Team Clinic The Team - Nurse specialist - ≥ 2 interventional cardiologists - ≥ 2 cardiac surgeons The Set up - specific office on a scheduled day - concomitant visit with common decision - evaluation and follow up Multidisciplinary meeting Once a week Review data and confirm indication Follow up “Time” Communication between the Team Information to patient, Family Inform consent Follow up

Diagnostic: Anatomic, Measures Before, During, After and Follow up Imaging Modalities Echocardiography (required) TTE, TEE Additional aortic root, AI, left ventricle, and mitral valve imaging Angiography Imaging (required) Coronary artery anatomy Aortic root anatomy Aortic arch anatomy Abdominal aorta Peripheral vasculature CT Imaging (recommended) Aortic root and arch anatomy Abdominal aorta Peripheral vascular anatomy 3D rendering MRI Purpose: Which imaging modalities should be used to assess the suitability of a CoreValve candidate? Ideally, as many imaging modalities as possible should be used because the information obtained from each modality is complimentary and confirmatory. As a minimum, two modalities should be used to assess a patient’s anatomical conditions. If there are any doubts or misgivings about the actual data – a third diagnostic modality should be used. Diagnostic: Anatomic, Measures Before, During, After and Follow up

Team Planning Day Before Procedure Pre-evaluation of the procedure (IC, CS, CAnesth) Review Risk Assessment and determine strategy accordingly Confirm vascular access and procedural plan Anesthesia local, general, assess airway intubation Review anatomy (angulation, calcification, size, etc.) Potential complications and treatments Access site, choice of sheath (hemostasis, potential need for retrieval), closure, tortuosity, treatment of potential perforation …) Reserve blood, bed, physiotherapy …  Confirm availability of rescue equipment (snares, covered stents, closure balloons, etc.)  Talk to patient and family Obtain signed Inform Consent Purpose:

Cath-Lab Equipment: the “Best” no compromise Personnel: “dedicated” Hybrid room vs Cath lab Devices: “all” Personnel: “dedicated” Nurses Cath lab tech X rays tech Echo tech MDs

Desired skill set from Interventionalist Experience with the different cath-lab procedures and devices (Aortic Valvuloplasty; this is the backbone of TAVI procedure. Cumulative experience of about 50-100 BAVs will greatly increase operator comfort) Working knowledge of TEE and CT Knowledge of Peripheral Vascular Interventions/AAA procedures-large catheters, pre-closure techniques, covered stents, up and over technique etc

Desired skill set from the Surgeon Experience with Percutaneous approaches Endovascular skills: Increases familiarity with wire skills and cath lab environment Working knowledge of TEE and CT Ability to play in the “sand-box” with the interventionalist

Team Cath-Lab Set up Communication Valve Preparation Table Anesthesia Monitors Valve Preparation Table Echo Sterile Table Other Back-up Equipment Communication

Team Post Procedure surveillance Hemodynamics Heart Rhythm Disturbances Bleeding Complications Limb Ischemia Deep Vein Thrombosis and Pulmonary Embolism Neurological Complications Renal Function Infections Gastrointestinal Complications Purpose:

Team Follow up Evaluation pre-discharge: Follow up: Clinical evaluation. Heart rhythm disturbances, quality of vascular access and functional evaluation of the intervention Follow up: At the clinic By the Team Clinical and imaging evaluation

Conclusion Team work Time consuming Total commitment and “respect” of the respective skills, knowledge and competence. Training the Team together and improving communication. Tailoring the future of the Structural Heart Intervention

CoreValve Bioprosthesis Design Tissue mass distributed over greater height More compressible Smaller French size catheter CoreValve Bioprosthesis Design Suspension bridge concept L1 L2 L3 Static Frame design = Fixed post equivalent Even load (L) distribution L1 = L2 = L3 Load absorbed equally by each point on leaflet commissures NO frame flexing under load Less tissue mass needed in post area